Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.
Marisavljević
Dragomir
D
Ristić
Biljana
B
Hajder
Jelena
J
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003872:Dermatitis / Q000000981:diagnostic imaging*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008466:Mechlorethamine; D011241:Prednisone; D011344:Procarbazine; D011877:Radionuclide Imaging; D014750:Vincristine; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone; D000093542:Gemcitabine